Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FULC - Fulcrum Therapeutics Inc


IEX Last Trade
8.55
-0.190   -2.222%

Share volume: 493,652
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$8.74
-0.19
-2.17%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
42%
Profitability 25%
Dept financing 3%
Liquidity 75%
Performance 60%
Company vs Stock growth
vs
Performance
5 Days
-6.76%
1 Month
1.66%
3 Months
11.76%
6 Months
-17.15%
1 Year
51.33%
2 Year
18.92%
Key data
Stock price
$8.55
P/E Ratio 
-26.37
DAY RANGE
N/A - N/A
EPS 
-$0.32
52 WEEK RANGE
$3.14 - $13.70
52 WEEK CHANGE
$0.49
MARKET CAP 
533.527 M
YIELD 
N/A
SHARES OUTSTANDING 
62.401 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
2.19
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$791,841
AVERAGE 30 VOLUME 
$838,160
Company detail
CEO:
Region: US
Website: fulcrumtx.com
Employees: 111
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

what if we could regulate genes, not just discover them? what if we could treat disease at their genetic source? what if we could integrate multiple disciplines to develop breakthrough medicines? what if you could be a part of a passionate team committed to the patients we serve? we can. we will. we are. join us. we are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. a fulcrum is defined as the point on which a lever rests, balances and pivots. fulcrum therapeutics is intervening in gene regulatory mechanisms to unlock the information contained in the human genome. the fulcrum product engine is dedicated to bringing balance to the genetic on and off switches in disease. our approach the sequencing of the human genome has provided incredible insight into disease biology, yet the richness of biology comes from the dynamic on and off switches that control the genome – gene regulation. the fulcrum product eng

Recent news